StonvexLoading…
StonvexStonvexStonvexCore line items from ALGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-03-27 | Q4 2025 2025-12-26 | Q3 2025 2025-09-26 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $890.10M | $646.91M | $417.70M | $203.41M |
Operating Income | $18.49M | $13.08M | $3.50M | $-2.74M |
Net Income | $-14.90M | $1.59M | $-6.71M | $-13.23M |
EPS (Diluted) | $-0.08 | $0.01 | $-0.04 | $-0.07 |
Total Assets | $1.42B | $1.42B | $1.38B | $1.39B |
Total Liabilities | $459.73M | $458.30M | $438.50M | $464.95M |
Cash & Equivalents | $168.75M | $155.19M | $117.49M | $129.11M |
Free Cash Flow OCF − CapEx | $124.89M | $106.19M | $64.94M | $51.02M |
Shares Outstanding | 185.36M | 185.23M | 185.11M | 184.94M |